Characterizing the human leukocyte antigen (HLA) bound ligandome by mass spectrometry (MS) holds great promise for developing vaccines and drugs for immune-oncology. Still, the …
Immunopeptidomics is a key technology in the discovery of targets for immunotherapy and vaccine development. However, identifying immunopeptides remains challenging due to …
The inclusion of peptide retention time prediction promises to remove peptide identification ambiguity in complex liquid chromatography–mass spectrometry identification workflows …
Immunopeptidomics aims to identify major histocompatibility complex (MHC)-presented peptides on almost all cells that can be used in anti-cancer vaccine development. However …
Interest in the use of machine learning for peptide fragmentation spectrum prediction has been strongly on the rise over the past years, especially for applications in challenging …
MS²PIP is a data-driven tool that accurately predicts peak intensities for a given peptide's fragmentation mass spectrum. Since the release of the MS²PIP web server in 2015, we have …
DP Zolg, S Gessulat, C Paschke… - Rapid …, 2021 - Wiley Online Library
Database search engines for bottom‐up proteomics largely ignore peptide fragment ion intensities during the automated scoring of tandem mass spectra against protein databases …
In the last decade, a revolution in liquid chromatography-mass spectrometry (LC-MS) based proteomics was unfolded with the introduction of dozens of novel instruments that …
H Liao, C Barra, Z Zhou, X Peng, I Woodhouse… - Nature …, 2024 - nature.com
Understanding the nature and extent of non-canonical human leukocyte antigen (HLA) presentation in tumour cells is a priority for target antigen discovery for the development of …